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Hypertension is a major public health problem. However,
no estimates of age- and sex-specific incidences are available
for the Spanish population. Our objective was to estimate
the incidence of hypertension in a cohort of university
graduates in Spain. We followed up 5648 individuals aged
25-65 years who were initially free of hypertension, diabetes,
and cardiovascular disease for a median of 30 months. New
diagnoses of hypertension were identified using mailed
questionnaires. We validated the self-reported diagnosis of
hypertension. In 18 250 person-years of follow-up, we
identified 248 new cases of hypertension. The unadjusted
incidences of hypertension in women and men were 8.2 per
1000 person-years (95% CI, 6.7-10.1) and 21.8 per 1000
person-years (95% CI, 18.6-25.4), respectively. The
cumulative probability of receiving a medical diagnosis of
hypertension by the age of 65 years was 50% among women
and 72% among men. In conclusion, we have provided new
evidence confirming that hypertension is one of the most
important public health problems in Spain.
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Incidencia de hipertensión arterial en una
cohorte de graduados universitarios españoles:
el estudio SUN
La hipertensión arterial (HTA) es un importante proble-
ma de salud pública. Sin embargo, no hay estimaciones
en España de su incidencia específica por edad y sexo.
Nuestro objetivo fue estimar la incidencia de HTA en una
cohorte de universitarios. Se incluyó a 5.648 individuos
de 25-65 años de edad inicialmente libres de HTA, diabe-
tes y enfermedad cardiovascular, a los que se siguió du-
rante 30 meses. Se determinaron los nuevos diagnósti-
cos de HTA mediante cuestionarios. Se validaron los
diagnósticos autorreferidos de HTA. De 18.250 personas-
año de seguimiento identificamos 248 nuevos casos de
HTA. La incidencia bruta en mujeres (edad media, 33
años) y varones (edad media, 38 años) fue, respectiva-
mente, 8,2 (intervalo de confianza [IC] del 95%, 6,7-10,1)
y 21,8 (IC del 95%, 18,6-25,4) por 1.000 personas-año.
La probabilidad acumulada de recibir un diagnóstico mé-
dico de HTA a los 65 años fue del 50% en mujeres y del
70% en varones.
Palabras clave: Hipertensión arterial. Incidencia. Estu-
dios prospectivos. España.
INTRODUCTION
Despite the importance of hypertension (HT) as a
public health problem (high prevalence, impact on
morbimortality),1-3 there are no estimates reporting age-
and sex-specific incidence rates of HT in Spain. To our
knowledge, only the DRECE II Study reported the crude
cumulative incidence and the incidence rate of HT in a
population followed prospectively, but the authors did
not provide specific incidences for different age and sex
strata.4
Our objective was to describe the incidence rate of HT
according to age and sex in a prospective cohort, the
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Seguimiento Universidad de Navarra (SUN, University
of Navarra Follow-up) Study.
METHODS
Study Participants
The SUN study is a dynamic cohort of university
graduates, designed to study the association between
dietary factors and hypertension, obesity, and
cardiovascular disease. Its methods have been
described with detail elsewhere.5 Briefly, beginning
in December 1999, an invitation letter and a
questionnaire were sent to all graduates from the
University of Navarra, and members of some other
professional associations. The questionnaire gathered
information on sociodemographic variables, lifestyle
factors (smoking, physical activity, diet), and clinical
data (personal and family history of several
conditions). From December 1999 to December 2002,
11 555 individuals answered the questionnaire.
Subsequently, the follow-up of initial responders was
made through biennial mailed questionnaires, with
up to five mailings to those who did not reply. In
December 31, 2005, 9695 had answered the 2-year
and 5150 the 4-year follow-up questionnaire. Overall,
the follow-up proportion was 85%. The age range of
participants was 20 to 90 years old at baseline. For
this analysis, we included only participants in the age
range 25-65, and we excluded individuals reporting
at baseline a history of cardiovascular disease, cancer
or diabetes, those with prevalent HT, and those with
extreme caloric intakes or missing values for age, sex,
diet, body mass index or physical activity. Finally,
5648 persons were included in the study. The average
age was 33 years for women and 38 for men. The
Institutional Review Board of the University of
Navarra approved the study protocol.
Hypertension Ascertainment
In both the baseline and follow-up questionnaires, we
asked participants whether they have received a medical
diagnosis of HT. Additionally, the baseline questionnaire
inquired for the most recent systolic and diastolic BP.
The follow-up questionnaire also requested the date of
HT diagnosis.
A participant was considered to have HT at baseline
if she or he reported a medical diagnosis of HT, was
taking antihypertensive medication or reported a systolic
BP ≥140 mm Hg and/or a diastolic BP ≥90 mmHg.6 New
cases of HT were defined as those individuals reporting
a physician-diagnosis of HT in the follow-up questionnaire
and did not have HT at baseline.
A validation study was conducted in a random sample
of participants (n=127) in the metropolitan area of
Pamplona (Navarra, Spain). It showed an adequate
validity of the self-reported diagnosis of HT in this highly
educated cohort (positive predictive value: 82%, and
negative predictive value 85%) when a directly measured
value of BP (repeated twice) was used as the gold
standard.7
Statistical Analysis
For each participant, we computed person-time of
follow-up from the date of return of the baseline
questionnaire to the date of return of the last follow-up
questionnaire, or the date of diagnosis of HT for new
cases of the disease. Age and sex-specific incidence rates
of HT were computed as the number of new cases of HT
divided by the person-time of follow-up in each age-sex
group, and were summarized by calculating the
corresponding cumulative probability of having a
diagnosis of HT by age 65.8
RESULTS
From the 11555 initial responders, we excluded 3538
participants because of the presence of one or more of
the exclusion criteria. That left 8017 participants available
for the analysis. From them, 6776 answered the 2-year
and 3659 answered also the 4-year follow-up
questionnaire. The median follow-up was 30 months.
This represents a follow-up of 20031 person-years (study
base), 18250 person-years of the study base corresponded
to participants aged 25-65 years. Baseline characteristics
of women and men that responded the follow-up
questionnaire are shown in Table 1. Women in our
population were younger, leaner, less active, and had an
overall healthier dietary pattern than men.
Among women, 91 new cases of HT were identified,
and 157 among men. The crude incidence rate of HT
(95% confidence intervals) was 8.2 (6.7-10.1) per 1000
person-years of follow-up in women and 21.8 (18.6-25.4)
in men. Age- and sex-specific incidences rates, and their
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Age, y 33.3 (9.4) 38.2 (11.2)
Body mass index, kg/m2 21.8 (2.8) 25.0 (2.9)
Physical activity 22.0 (23.4) 30.3 (29.4)
(METs-hours/week)
Alcohol intake, g/d 3.8 (5.8) 9.7 (11.7)
Sodium intake, g/d 3.5 (2.1) 4.2 (2.6)
Low-fat dairy consumption, g/d 238.4 (253.7) 149.7 (216.5)
Vegetable consumption, g/d 539.2 (313.3) 454.6 (324.1)
Fruit consumption, g/d 341.7 (291.9) 284.3 (269.1)
Values are means (standard deviation)
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95% confidence intervals, are shown in Table 2. The
incidence rate of HT significantly increased with age,
and it was higher for men than for women across all age
categories (P<.05).
Under usual assumptions, including the supposition
of no competing risks,8 the cumulative probability of
being medically diagnosed of hypertension by age 65 in
this cohort was 50% in women and 70% in men.
DISCUSSION
In this study, we report for the first time age and
sex-specific incidence rates of HT in a large Spanish
cohort. Interestingly, we show a very high cumulative
incidence of a diagnosis of HT before age 65,
particularly among men. The observed cumulative
incidences were similar to prevalence estimates for
HT among European population older than 65.9 In
Spain, only the DRECE II Study reported incidence
rates of HT, but the authors did not report specific
incidences for different age and sex groups.4 Other
cohort studies have provided comparable age and sex-
specific incidences of HT.10-12
Our study has several methodological limitations. First,
the diagnosis of HT is based in self-reported data. We
have shown, however, the adequate validity of self-
reported HT diagnosis.7 Nonetheless, the observed
incidence of HT in this population most likely
underestimates the true incidence of HT, due to the
relatively high proportion of undiagnosed cases of HT
among the general population. The high educational level
of all members of the cohort probably reduced the impact
of underreporting.
Another potential limitation is the potential lack of
generalizability of our results to the Spanish population.
The participants in the SUN Study are all of them
university graduates, and most likely they follow healthier
lifestyles, implying that the reported rates of HT are
probably lower that the incidence rates in the general
Spanish population. Our aim, however, is not to provide
accurate data on the incidence of HT in Spain, but to add
new information to the epidemiology of HT beyond that
derived from prevalence data.
CONCLUSSIONS
In conclusion, in the absence of estimates of incidence
rates based on representative nation-wide surveys obtained
using direct measurements, our data shows that the
incidence of HT was relatively high in a defined Spanish
population, especially among men. This was more evident
when we considered the cumulative incidence of a HT
diagnosis by age 65. Studies conducted in the general
population, using direct measurement of BP, would allow
a better definition of the problem.
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